| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dianthus Therapeutics, Inc. (DNTH) has 5 insiders with recent SEC Form 4 filings, including 1 buy and 29 sells. DNTH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 89.7K | $7.40M | - | |
| Other | 16.2K | $1.33M | - | |
| VP | 8.0K | $659.8K | -26,530 | |
| Dir | 0 | - | - | |
| CEO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Randhawa Simrat73 | EVP, Head Of R&D | Sale+OE | 26,530 | $90.62 | $2,404,076.95 | -41.6% | - | - | |
| Mar 31, 2026 | Soteropoulos Paula75 | Director | Sale+OE | 599 | $80.11 | $47,985.89 | -100% | - | - | |
| Mar 31, 2026 | Savitz Ryan | EVP, CFO &Cbo | Sale+OE | 114,367 | $83.00 | $9,492,595.50 | -18.5% | - | - | |
| Mar 12, 2026 | Randhawa Simrat73 | EVP, Head Of R&D | Sale+OE | 33,830 | $81.48 | $2,756,468.40 | -100% | -4.9% | - | |
| Mar 12, 2026 | Carr Edward81 | Chief Accounting Officer | Sale+OE | 43,682 | $81.49 | $3,559,494.57 | -57.0% | -4.9% | - | |
| Mar 12, 2026 | Garcia Marino | CEO And President | Sale+OE | 122,918 | $81.49 | $10,016,380.63 | -56.3% | -4.9% | - | |
| Dec 4, 2025 | Savitz Ryan | CFO &Cbo | Sale+OE | 20,000 | $45.18 | $903,600.00 | -100% | +38.7% | - | |
| Nov 14, 2025 | Randhawa Simrat73 | EVP, Head Of R&D | Sale+OE | 196,538 | $37.55 | $7,379,887.46 | -67.2% | +16.2% | - | |
| Sep 9, 2025 | Savitz Ryan | CFO &Cbo | Sale+OE | 20,000 | $35.00 | $700,000.00 | -100% | +22.6% | - | |
| Sep 29, 2023 | Fairmount Funds Management LLC73 | Director, 10% Owner | Buy | 24,670 | $13.63 | $336,252.10 | +1.3% | -25.9% | +99.3% |